To analyze and evaluate the effects of 20% salicylic acid peel along with oral and topical antifungal therapy versus oral and topical antifungal therapy without 20% salicylic peel in the treatment of ringworm infections.
Phase 4
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2023/07/054952
- Lead Sponsor
- Pdiangty Giri Mawlong
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of either sex of age more than 18 years and less than 60 years having active superficial dermatophytosis.
Exclusion Criteria
1.Pregnant and lactating females
2.Active bacterial or viral infections
3.Involvement of major flexures
4.Patients with hypertension, diabetes, liver
diseases
5.Patient who recently apply topical steroid
6.Patients younger than 18 years
7.Patients with extensive involvement (more
than 20% body surface area)
8.Patients with history of hypersensitivity
to formulation used in the study
9.Severe systemic illness or malignancy
10.Patients having unrealistic expectations
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method